AEON Biopharma Inc. - Class A


AEON

Price

3.36


Change

-0.21


High

3.57


Low

3.24


Avg Volume

59,748


PE Ratio

NA


52 Week High

17.17


52 Week Low

3.24



Profile

we are a nasdaq-listed special purpose acquisition company whose business purpose is to effect a merger or similar business combination with one or more businesses. our acquisition strategy is to identify and complete our initial business combination with a medical technology company in the healthcare industry. our sponsor team consists of chairman/ceo robert palmisano, president vikram malik, cfo oleg grodnensky and chief legal officer david meredith.


Exchange

NYSE MKT LLC

Sector

Professional, Scientific, and Technical Services

CEO

Employees

3

Address

, ,

Website

Industry

Research and Development in Biotechnology

Tags

Phone

Top Streaming News


Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.

Data provided by IEX Cloud

About

Copyright © 2020 Finaza.IO. All Rights Reserved.